Feb 04, 2025 / 10:00AM GMT
Operator
Ladies and gentlemen, welcome to the Coloplast A/S Q1 2024, '25 earnings release conference call. I'm Valentina, the Chorus Call operator. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Kristian Villumsen, President and CEO. Please go ahead.
Kristian Villumsen - Coloplast A/S-President - Chief Executive Officer, Member of the Executive Management
Good morning, and welcome to our Q1 '24, '25 conference call. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions as we usually do.
Please turn to slide number 3. We delivered 8% organic growth and a reported EBIT margin before special items of [27%], which was in line with our expectations. Adjusted return on invested capital after tax and before special items was 15% on par of last year. Let me start
Q1 2025 Coloplast A/S Earnings Call Transcript
Feb 04, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers